Politics No more doom scrolling? A Meta trial loss could reshape social media Finance News Aug 21, 2026 Conceptual Portrait of Smartphone Addiction and Endless Scrolling.Marco_piunti | E+ | Getty ImagesThis report is from… Read More...
Investing Moderna, Merck Shares Soar on Cancer Vaccine Trial Success Finance News Aug 20, 2026 An experimental personalized mRNA vaccine developed by Moderna (NASDAQ:MRNA) and Merck & Company (NYSE:MRK)… Read More...
Markets Meta trial begins with states accusing social media giant of exploiting, Finance News Aug 19, 2026 Meta Platforms rejected accusations by U.S. states that it intentionally sought to addict children to its Facebook… Read More...
industry Meta social media addiction trial begins with Zuckerberg to testify Finance News Aug 17, 2026 Monte Mann, a partner at Armstrong Teasdale, discusses the social media addiction case brought against Meta by!-->-->… Read More...
Markets What’s at stake as Meta faces potential landmark trial in U.S. federal Finance News Aug 17, 2026 Meta, which has lost two trials concerning child safety on its platforms so far this year, faces what could be its… Read More...
Politics Novo Nordisk shares fall after heart medicine trial results Finance News Jul 31, 2026 Shares of Novo Nordisk fell as much as 10% on Friday after the drugmaker said a late-stage heart drug trial failed to… Read More...
Politics AstraZeneca’s trial flop raises bigger questions around its pipeline Finance News Jul 10, 2026 AstraZeneca's failed late-stage trial for Wainua was never expected to have a major financial impact on the… Read More...
Politics AstraZeneca stock dives 9% after heart drug trial misses target Finance News Jul 9, 2026 Shares of AstraZeneca fell as much as 9% after a late-stage clinical trial for a heart disease failed to meet its… Read More...
industry States seek $1.4 trillion from Meta over social media addiction trial Finance News Jul 7, 2026 Founder of Constellation Research Inc. Ray Wang discusses the volatile A.I. tech rally and Meta's shifting!-->-->… Read More...
Politics Abivax stock sinks over 30% after bowel disease drug trial update Finance News Jun 2, 2026 Shares of French biotech Abivax tumbled as much 32% after it reported fresh data on its lead asset, a drug for… Read More...